Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1990-05-17
1992-03-24
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
435106, 4352535, 562567, A61K 31195
Patent
active
050989359
ABSTRACT:
A new antibiotic, named Conagenin, is provided which can exhibit useful carcinostatic or antitumor activities on carcinomas and tumors, particularly malignant tumors, of mammalian animals including man. Conagenin can be produced by fermentation of microorganisms of genus Streptomyces, typically Streptomyces roseosporus MI696-AF3 strain identified under the deposit number FERM BP-2738. Conagenin has formula (I) and is useful for medicinal purposes, particularly as carcinostatic agent or antitumor agent for inhibiting carcinomas and malignant tumors of mammalian animals, including man.
REFERENCES:
patent: 2856421 (1958-10-01), Hasbrouck
patent: 3856854 (1974-12-01), Schnettler
Hamada Masa
Iinuma Hironobu
Ishizuka Masaaki
Isshiki Kunio
Maeda Kenji
Kanegafuchi Kagaku Kogyo & Kabushiki Kaisha
Shippen Michael L.
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
LandOfFree
Carcinostatic or antitumor antibiotic, conagenin, and production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carcinostatic or antitumor antibiotic, conagenin, and production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carcinostatic or antitumor antibiotic, conagenin, and production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2010664